Used in medicinal chemistry as a key intermediate in the synthesis of boron-containing pharmaceuticals, particularly in the development of protease inhibitors. Its boronic acid moiety enables reversible binding to biological targets, making it valuable in designing enzyme inhibitors for therapeutic applications. Also employed in Suzuki-Miyaura cross-coupling reactions as a boron source in the preparation of biaryl compounds for drug discovery.